Karen Jacobson-Sive

Molecular Lesions in Low-Risk Myelodysplastic Neoplasms Disrupt Prognostic Model for Leukemia

The inclusion of molecular lesion data in prognostic models for predicting overall survival (OS) for patients with low-risk myelodysplastic neoplasms (LR-MDS) causes bone marrow (BM) blast percentage and other traditional OS prognostic parameters to lose clinical significance, according to a

Molecular Lesions in Low-Risk Myelodysplastic Neoplasms Disrupt Prognostic Model for Leukemia Read More »